Risk variants and haplotypes in dopamine metabolism genes, DBH [34], DDC [35], MAOA [35], and SLC6A3 [36], are reported to influence migraine risk, as are variants in the oestrogen receptor gene, ESR1 [37, 38]. This evidence concerns the gene DBH and migraine disorder.